Insider Trading Alert - MACK, POOL And GPS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 24, 2014, 63 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $452.23 to $11,250,120.00.

Highlighted Stocks Traded by Insiders:

Merrimack Pharmaceuticals (MACK) - FREE Research Report

Porter Michael E, who is Director at Merrimack Pharmaceuticals, bought 32,390 shares at $6.84 on June 24, 2014. Following this transaction, the Director owned 568,255 shares meaning that the stake was boosted by 6.04% with the 32,390-share transaction.

The shares most recently traded at $7.35, up $0.51, or 6.94% since the insider transaction. Historical insider transactions for Merrimack Pharmaceuticals go as follows:

  • 4-Week # shares bought: 4,000
  • 12-Week # shares bought: 90,000
  • 24-Week # shares bought: 90,000

The average volume for Merrimack Pharmaceuticals has been 2.2 million shares per day over the past 30 days. Merrimack Pharmaceuticals has a market cap of $723.8 million and is part of the health care sector and drugs industry. Shares are up 34.31% year-to-date as of the close of trading on Tuesday.

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. Currently, there are 3 analysts who rate Merrimack Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MACK - FREE

TheStreet Quant Ratings rates Merrimack Pharmaceuticals as a sell. Among the areas we feel are negative, one of the most important has been weak operating cash flow. Get the full Merrimack Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Pool (POOL) - FREE Research Report

Haymaker George T, who is Director at Pool, sold 2,500 shares at $57.13 on June 24, 2014. Following this transaction, the Director owned 27,086 shares meaning that the stake was reduced by 8.45% with the 2,500-share transaction.

The shares most recently traded at $57.30, up $0.17, or 0.29% since the insider transaction. Historical insider transactions for Pool go as follows:

  • 4-Week # shares sold: 2,517
  • 12-Week # shares sold: 2,517
  • 24-Week # shares sold: 2,517

The average volume for Pool has been 238,500 shares per day over the past 30 days. Pool has a market cap of $2.6 billion and is part of the consumer goods sector and consumer durables industry. Shares are down 1.14% year-to-date as of the close of trading on Tuesday.

Pool Corporation distributes swimming pool and related backyard products primarily in North America and Europe. The company offers approximately 160,000 national brand and its own-branded products to wholesale customers. The stock currently has a dividend yield of 1.54%. The company has a P/E ratio of 27.6. Currently, there are 2 analysts who rate Pool a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on POOL - FREE

TheStreet Quant Ratings rates Pool as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, revenue growth, notable return on equity, good cash flow from operations and compelling growth in net income. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Pool Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Gap (GPS) - FREE Research Report

Simmons Sabrina, who is Evp Cfo at Gap, sold 12,369 shares at $41.74 on June 24, 2014. Following this transaction, the Evp Cfo owned 0 shares meaning that the stake was reduced by 100% with the 12,369-share transaction.

The shares most recently traded at $41.44, down $0.30, or 0.73% since the insider transaction. Historical insider transactions for Gap go as follows:

  • 4-Week # shares sold: 508,416
  • 12-Week # shares sold: 570,416
  • 24-Week # shares sold: 570,416

The average volume for Gap has been 4.1 million shares per day over the past 30 days. Gap has a market cap of $18.4 billion and is part of the services sector and retail industry. Shares are up 6.47% year-to-date as of the close of trading on Tuesday.

The Gap, Inc. operates as an apparel retail company worldwide. It provides apparel, accessories, and personal care products for men, women, and children under the Gap, Banana Republic, Old Navy, Piperlime, Athleta, and Intermix brands. The stock currently has a dividend yield of 2.11%. The company has a P/E ratio of 16.0. Currently, there are 9 analysts who rate Gap a buy, no analysts rate it a sell, and 17 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GPS - FREE

TheStreet Quant Ratings rates Gap as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Gap Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers